European Association for Hemophilia and Allied Disorders (EAHAD 2026) 3 - 6 February 2026

Real-world efficacy and safety of concizumab in patients with haemophilia B with inhibitors from the early access program in France

Authors :

Alexandre Butelet,¹ Christine Biron-Andréani,² Valérie Chamouard,^3-4 Catherine Chatelanaz,⁵ Vincent Cussac,⁵ Roseline d’Oiron,^6-7 Yesim Dargaud,^3-4 Stéphanie Desage,⁴ Hélène Gatti,⁸ Antoine Rauch,⁹ Sophie Susen,⁹ Caroline Galeotti6

Affiliations

View Details Hide Details

Download poster (.pdf)

Search Science Hub

Are you a healthcare professional?

Real-world efficacy and safety of concizumab in patients with haemophilia B with inhibitors from the early access program in France